Ventyx Biosciences, Inc (VTYX) insider trading
Every open-market stock purchase and sale by Ventyx Biosciences, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $463K over the last 12 months (2 sales). No open-market buys.
- Last insider buy: Sheila Gujrathi (Insider), $301K, 21 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $463K (2 sales). Last close $14.00 on Mar 2, 2026.
Recent VTYX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Mar 4, 2026 | Raju Mohan (CEO) | Sold (not open market) | $9.6M |
| Mar 4, 2026 | Raju Mohan (CEO) | Sold (not open market) | $6.8M |
| Mar 4, 2026 | Sheila Gujrathi (Insider) | Sold (not open market) | $5.2M |
| Mar 4, 2026 | Raju Mohan (CEO) | Sold (not open market) | $4.5M |
| Mar 4, 2026 | Sheila Gujrathi (Insider) | Sold (not open market) | $4M |
| Mar 4, 2026 | John Nuss (C-suite exec) | Sold (not open market) | $3.7M |
| Mar 4, 2026 | Raju Mohan (CEO) | Sold (not open market) | $2.7M |
| Mar 4, 2026 | Roy Gonzales (VP) | Sold (not open market) | $2.4M |
| Mar 4, 2026 | John Nuss (C-suite exec) | Sold (not open market) | $2.1M |
| Mar 4, 2026 | John Nuss (C-suite exec) | Sold (not open market) | $2M |
| Mar 4, 2026 | Matthew Richard Moore (COO) | Sold (not open market) | $1.6M |
| Mar 4, 2026 | John Nuss (C-suite exec) | Sold (not open market) | $1.5M |
| Mar 4, 2026 | Raju Mohan (CEO) | Sold (not open market) | $1.5M |
| Mar 4, 2026 | Raju Mohan (CEO) | Sold (not open market) | $1M |
| Mar 4, 2026 | John Nuss (C-suite exec) | Sold (not open market) | $888K |
| Mar 4, 2026 | William Richard White (Insider) | Sold (not open market) | $718K |
| Mar 4, 2026 | Onaiza Cadoret-Manier (Insider) | Sold (not open market) | $698K |
| Mar 4, 2026 | Allison Hulme (Insider) | Sold (not open market) | $698K |
| Mar 4, 2026 | Mark S Forman (C-suite exec) | Sold (not open market) | $683K |
| Mar 4, 2026 | Allison Hulme (Insider) | Sold (not open market) | $555K |
| Mar 4, 2026 | Sheila Gujrathi (Insider) | Sold (not open market) | $555K |
| Mar 4, 2026 | Somu Subramaniam (Insider) | Sold (not open market) | $555K |
| Mar 4, 2026 | Onaiza Cadoret-Manier (Insider) | Sold (not open market) | $555K |
| Mar 4, 2026 | William Richard White (Insider) | Sold (not open market) | $555K |
| Mar 4, 2026 | John Nuss (C-suite exec) | Sold (not open market) | $388K |
Who's trading VTYX
- John Nuss, C-suite exec: sold $97.8K (1 sale), last Mar 4, 2026
- William Richard White, Insider: other filings, last Mar 4, 2026
- Mark S Forman, C-suite exec: other filings, last Mar 4, 2026
- Sheila Gujrathi, Insider: other filings, last Mar 4, 2026
- Roy Gonzales, VP: other filings, last Mar 4, 2026
- Matthew Richard Moore, COO: other filings, last Mar 4, 2026
- Somu Subramaniam, Insider: other filings, last Mar 4, 2026
- Allison Hulme, Insider: other filings, last Mar 4, 2026
- Onaiza Cadoret-Manier, Insider: other filings, last Mar 4, 2026
- Raju Mohan, CEO: sold $365K (1 sale), last Mar 4, 2026
Get free alerts when an insider at Ventyx Biosciences, Inc files a new trade →